SC 13G

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Filing Date
Apr 23, 2015
Document Date
Apr 23, 2015
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
KemPharm
Issuer
KEMPHARM, INC